Spanish Red Biotech Pipeline

MSD

MK6482

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: MK-6482 Versus Everolimus in Participants With Advanced Renal Cell Carcinoma That has Progressed After Prior PD-1/L1 and VEGF-Targeted Therapies.
Phase: 3Phase III in Spain, 2Phase II, 1Phase I